Exodus Point Capital Management, LP Veracyte, Inc. Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Veracyte, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 734,448 shares of VCYT stock, worth $28.8 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
734,448
Previous 798,641
8.04%
Holding current value
$28.8 Million
Previous $17.3 Million
44.46%
% of portfolio
0.15%
Previous 0.12%
Shares
12 transactions
Others Institutions Holding VCYT
# of Institutions
308Shares Held
81.8MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$305 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$304 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$197 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$193 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$166 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.81B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...